tiprankstipranks
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market

Kazia Therapeutics (KZIA) Income Statement

Compare
281 Followers

Kazia Therapeutics Income Statement

Last quarter (Q2 2024), Kazia Therapeutics's total revenue was AU$5.00, an increase of Infinity% from the same quarter last year. In Q2, Kazia Therapeutics's net income was AU$-8.82M. See Kazia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 2.31MAU$ 555.00AU$ 25.00AU$ 15.18MAU$ 1.06K
Gross Profit
AU$ 2.31MAU$ 555.00AU$ 25.00AU$ 15.18MAU$ 1.06K
Operating Expenses
AU$ 2.31MAU$ 24.12MAU$ 24.88MAU$ 24.13MAU$ 13.16M
Depreciation and Amortization
AU$ 1.87MAU$ 1.87MAU$ 1.87MAU$ 1.26MAU$ 1.08M
EBITDA
AU$ -26.77MAU$ -22.28MAU$ -23.51MAU$ -5.11MAU$ -11.11M
Operating Income
AU$ 0.00AU$ -24.12MAU$ -26.70MAU$ -6.38MAU$ -12.53M
Other Income/Expenses
AU$ -27.05MAU$ 3.39MAU$ 0.00AU$ -2.53MAU$ -569.58K
Pretax Income
AU$ -27.05MAU$ -20.74MAU$ -25.02MAU$ -8.91MAU$ -12.77M
Net Income
AU$ -26.78MAU$ -20.47MAU$ -24.65MAU$ -8.42MAU$ -12.47M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -11.17AU$ -1.12AU$ -1.86AU$ -0.07AU$ -1.71
Diluted EPS
AU$ -11.17AU$ -1.11AU$ -1.86AU$ -0.07AU$ -1.71
Weighted Average Shares Outstanding
2.40M 18.22M 13.25M 117.63M 7.31M
Weighted Average Shares Outstanding (Diluted)
2.40M 18.43M 13.25M 117.67M 7.31M
Currency in AUD

Kazia Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis